APA (7th ed.) Citation

Nikolaidi, A., Liontos, M., Dadouli, K., Fountzilas, E., Papakotoulas, P., Papaxoinis, G., . . . Fountzilas, G. (2025). Real-world efficacy and safety data of the use of PARP inhibitors in advanced ovarian cancer: The experience of the Hellenic Cooperative Oncology Group. European Journal of Gynaecological Oncology, 46(12), 1. https://doi.org/10.22514/ejgo.2025.140

Chicago Style (17th ed.) Citation

Nikolaidi, Adamantia, et al. "Real-world Efficacy and Safety Data of the Use of PARP Inhibitors in Advanced Ovarian Cancer: The Experience of the Hellenic Cooperative Oncology Group." European Journal of Gynaecological Oncology 46, no. 12 (2025): 1. https://doi.org/10.22514/ejgo.2025.140.

MLA (9th ed.) Citation

Nikolaidi, Adamantia, et al. "Real-world Efficacy and Safety Data of the Use of PARP Inhibitors in Advanced Ovarian Cancer: The Experience of the Hellenic Cooperative Oncology Group." European Journal of Gynaecological Oncology, vol. 46, no. 12, 2025, p. 1, https://doi.org/10.22514/ejgo.2025.140.